These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 32614875)

  • 1. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
    Broberg G; Gyrd-Hansen D; Miao Jonasson J; Ryd ML; Holtenman M; Milsom I; Strander B
    Int J Cancer; 2014 May; 134(9):2223-30. PubMed ID: 24127304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
    Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
    Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing participation in cervical screening by targeting long-term nonattenders: Randomized health services study.
    Elfström KM; Sundström K; Andersson S; Bzhalava Z; Carlsten Thor A; Gzoul Z; Öhman D; Lamin H; Eklund C; Dillner J; Törnberg S
    Int J Cancer; 2019 Dec; 145(11):3033-3039. PubMed ID: 31032904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial.
    Broberg G; Jonasson JM; Ellis J; Gyrd-Hansen D; Anjemark B; Glantz A; Söderberg L; Ryd ML; Holtenman M; Milsom I; Strander B
    Int J Cancer; 2013 Jul; 133(1):164-71. PubMed ID: 23233356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology.
    Zehbe I; Jackson R; Wood B; Weaver B; Escott N; Severini A; Krajden M; Bishop L; Morrisseau K; Ogilvie G; Burchell AN; Little J
    BMJ Open; 2016 Oct; 6(10):e011754. PubMed ID: 27855089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: A cross-sectional study.
    Chaw L; Lee SHF; Ja'afar NIH; Lim E; Sharbawi R
    PLoS One; 2022; 17(3):e0262213. PubMed ID: 35287163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial.
    Szarewski A; Cadman L; Mesher D; Austin J; Ashdown-Barr L; Edwards R; Lyons D; Walker J; Christison J; Frater A; Waller J
    Br J Cancer; 2011 Mar; 104(6):915-20. PubMed ID: 21343937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study.
    Wikström I; Lindell M; Sanner K; Wilander E
    Br J Cancer; 2011 Jul; 105(3):337-9. PubMed ID: 21730977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer.
    Gyllensten U; Sanner K; Gustavsson I; Lindell M; Wikström I; Wilander E
    Br J Cancer; 2011 Aug; 105(5):694-7. PubMed ID: 21811250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
    Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
    BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.
    Sultana F; English DR; Simpson JA; Brotherton JM; Drennan K; Mullins R; Heley S; Wrede CD; Saville M; Gertig DM
    BMC Cancer; 2014 Mar; 14():207. PubMed ID: 24646201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland.
    Virtanen A; Anttila A; Nieminen P
    BMC Womens Health; 2015 Nov; 15():99. PubMed ID: 26542953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
    Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
    Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.
    Snijders PJ; Verhoef VM; Arbyn M; Ogilvie G; Minozzi S; Banzi R; van Kemenade FJ; Heideman DA; Meijer CJ
    Int J Cancer; 2013 May; 132(10):2223-36. PubMed ID: 22907569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of sending a direct send HPV self-sampling kit to long-term non-attenders in an organized cervical screening program.
    Sahlgren H; Sparén P; Elfgren K; Miriam Elfström K
    Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():68-73. PubMed ID: 34875556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening.
    Darlin L; Borgfeldt C; Forslund O; Hénic E; Hortlund M; Dillner J; Kannisto P
    J Clin Virol; 2013 Sep; 58(1):155-60. PubMed ID: 23867008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil.
    Castle PE; Silva VRS; Consolaro MEL; Kienen N; Bittencourt L; Pelloso SM; Partridge EE; Pierz A; Dartibale CB; Uchimura NS; Scarinci IC
    Cancer Prev Res (Phila); 2019 Mar; 12(3):159-170. PubMed ID: 30651294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.